In the summer of 2018, the FDA learned that some generic ARB medications, including valsartan, irbesartan, losartan and others contained nitrosamine impurities— including N-Nitrosodimethylamine (NDMA) ...
Elemental impurity risk management can help biomanufacturers to maintain regulatory alignment and ensure patient safety.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results